Landauer, Inc. (NYSE:LDR) was upgraded by investment analysts at Hilliard Lyons from an “underperform” rating to a “neutral” rating in a research report issued to clients and investors on Wednesday, September 6th.
Several other analysts also recently weighed in on LDR. Zacks Investment Research downgraded Landauer from a “buy” rating to a “hold” rating in a research note on Wednesday, May 10th. BidaskClub downgraded Landauer from a “sell” rating to a “strong sell” rating in a research note on Tuesday, August 1st.
Shares of Landauer (NYSE LDR) traded up 0.59% on Wednesday, reaching $67.75. The company’s stock had a trading volume of 262,146 shares. The stock has a market cap of $652.97 million, a PE ratio of 35.09 and a beta of 1.27. Landauer has a 12-month low of $41.00 and a 12-month high of $68.50. The firm has a 50 day moving average price of $61.53 and a 200-day moving average price of $54.17.
Landauer (NYSE:LDR) last posted its quarterly earnings results on Tuesday, August 8th. The scientific and technical instruments company reported $0.67 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.49 by $0.18. The business had revenue of $39.89 million for the quarter. Landauer had a return on equity of 80.03% and a net margin of 12.09%. Equities research analysts expect that Landauer will post $1.95 EPS for the current year.
TRADEMARK VIOLATION WARNING: “Landauer, Inc. (NYSE:LDR) Rating Increased to Neutral at Hilliard Lyons” was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this news story on another domain, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The legal version of this news story can be accessed at https://ledgergazette.com/2017/09/16/landauer-inc-ldr-raised-to-neutral-at-hilliard-lyons.html.
Several institutional investors and hedge funds have recently modified their holdings of LDR. Vanguard Group Inc. boosted its stake in shares of Landauer by 4.2% in the first quarter. Vanguard Group Inc. now owns 848,773 shares of the scientific and technical instruments company’s stock worth $41,377,000 after buying an additional 34,013 shares during the last quarter. Renaissance Technologies LLC boosted its stake in shares of Landauer by 11.6% in the first quarter. Renaissance Technologies LLC now owns 274,600 shares of the scientific and technical instruments company’s stock worth $13,387,000 after buying an additional 28,600 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Landauer by 8.7% in the second quarter. Dimensional Fund Advisors LP now owns 295,696 shares of the scientific and technical instruments company’s stock worth $15,465,000 after buying an additional 23,718 shares during the last quarter. Marshall Wace North America L.P. purchased a new stake in shares of Landauer in the second quarter worth about $1,198,000. Finally, Bernzott Capital Advisors boosted its stake in shares of Landauer by 5.0% in the second quarter. Bernzott Capital Advisors now owns 447,156 shares of the scientific and technical instruments company’s stock worth $23,386,000 after buying an additional 21,250 shares during the last quarter. Hedge funds and other institutional investors own 80.99% of the company’s stock.
Landauer, Inc is a provider of technical and analytical services to determine occupational and environmental radiation exposure. The Company is a provider of outsourced medical physics services, and a provider of radiology related medical products. The Company operates through three segments: Radiation Measurement, Medical Physics and Medical Products.
Receive News & Ratings for Landauer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Landauer Inc. and related companies with MarketBeat.com's FREE daily email newsletter.